Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

Calling for Nominations to the EDU Committee & its online subcommittee

November 7, 2023Education Committee (EDU)

Statement on Middle East

October 27, 2023

GEC announces the Competition-4-Ideas Winners

October 4, 2023Iranian Society of Immunology, Italian Society of Immunology, Clinical Immunology & Allergology and 3 more

Funding Opportunity from IUIS and FOCIS for Young Immunologists from the Developing World

September 27, 2023Federation of Clinical Immunology Societies, Gender Equality Committee (GEC)

Immuno-Mexico 2024: Mechanisms for Immunotherapies

September 26, 2023Sociedad Mexicana de Inmunologia, Latin American and Caribbean Association for Immunology and 1 more

2023 Day of Immunology Winners

September 8, 2023American Association of Immunologists (AAI), Sociedade Portuguesa de Imunologia and 3 more

Two fellowships available to attend the Spring School of the German Society for Immunology

September 5, 2023Education Committee (EDU)

ASI announces their new ASI Global Outreach Award

August 9, 2023Latin American and Caribbean Association for Immunology, Gender Equality Committee (GEC)

FIMSA Travel Awards for IUIS 2023 Congress

June 20, 2023Federation of Immunological Societies of Asia-Oceania (FIMSA)